A continuous glucose monitor (CGM) for people living with diabetes that allows you to see glucose levels, trends and alerts on your mobile device.
Now available for both iOS and Android™ Devices.
To check compatibility for your mobile device click here.
Continuous glucose monitoring (CGM) systems track glucose levels, every few minutes, 24/7 through a tiny sensor inserted under your skin, either on your belly or arm using an automatic inserter. The sensor measures your interstitial glucose level, which is the glucose found in the fluid between the cell. CGM therapy can be used with or without an insulin pump.
Smart CGM predicts future high and low sensor glucose events up to an hour in advance and provides access to information that can inform you of clinically relevant glucose patterns.†
Measures sensor glucose 24/7 and sends alerts when a high or low is detected. Without predictive alerts turned on, it has a 90.5% hypoglycemia detection rate (when worn on the abdomen). With predictive alerts turned on and set at 30 minutes before a low, the Guardian™ Connect system had a 98.5% hypoglycemic detection rate (when worn on the abdomen. With this information, you can take action to help avoid highs and lows.2,3
Discreetly view your glucose reading on your smart phone. Get notifications on your mobile device and smart watch.
Trend arrows provide insight on the speed and direction your glucose is heading, customizable predictive alerts help you take action sooner.
You decide in advance when you want to be alerted between 10-60 minutes in 5 minute increments. Minimum two calibrations per day required.
Only available for iOS Devices.
The Sugar.IQ™ assistant supercharges the Guardian™ Connect system’s smarts by giving you a big picture view of your glucose patterns – and the factors that affect them.
We will get started on determining your insurance or pharmacy coverage. A member of our team will reach out to you for additional information. If you have questions please contact us at 888-882-8602 (M-F 9 AM-6 PM CDT).
The Guardian™ Connect continuous glucose monitoring (CGM) system is the standalone CGM system from Medtronic designed from the ground up to help serve the needs of customers on multiple daily insulin injections. Leveraging both modern mobile technology and the latest advances from Medtronic, the Guardian™ Connect system provides a smarter† way to manage your diabetes.
Guardian™ Connect system individuals can:
The Guardian™ Connect system is the only CGM system with customizable predictive alerts that helps you outsmart both highs and lows. Using smart technology to predict where your glucose levels are headed, the system can alert you from 10 to 60 minutes before a high or low.
Exclusively available to patients using the Guardian™ Connect system, the Sugar.IQ™ diabetes assistant app (only available on iOS) to continually analyze how glucose levels react to food, exercise and insulin. Together, the Guardian™ Connect system and the Sugar.IQ™ app turn hidden patterns into personalized insights that can help patients make smarter diabetes decisions.1
The Guardian™ Connect system compatibility information can be found by visiting Guardian™ Connect FAQs.
You should confirm compatibility with the Guardian™ Connect system using this link before updating your operating system.
The transmitter used with the pump system is different and doesn’t have Bluetooth® connectivity so it isn’t compatible with the Guardian™ Connect app. The MiniMed™ 600-series pumps use the Guardian™ Link 3 transmitter, which uses a different wireless technology to communicate with the pump. The transmitter shell for the Guardian™ Connect system also has a “GC” etched on the surface opposed to the pump system transmitter shell, which just has a “G.”
Anytime access to glucose levels and auto uploads to the CareLink™ Personal software when connected to the internet via wifi/mobile data.
Stay connected to your family and friends with automatic text message alerts when connected to the internet via wifi/mobile data.
We check your insurance and pharmacy benefits for coverage. You choose the one that is best for you.
We have your back. Our 24-Hour Technical Support is staffed 24/7.
Our team of dedicated clinicians will help guide you through training and ongoing support, our goal is that you StartRight™.
Peace of mind: we’ll replace your device. See conditions.
No regrets: if you’re not happy with our product, you can return it within 30-days – no questions asked.
1. The system is intended to complement, not replace, information obtained from standard blood glucose monitoring devices. All therapy adjustments should be based on measurements obtained from standard blood glucose monitoring devices. All therapy adjustments should be based on measurements obtained using a home blood glucose meter and not on values provided by the system. Alerts must be set to receive predictive alerts.
2. Guardian™ Connect system SSED, page 19, Table 5. 90.5% Glucose Correct Detection Rate without Predictive Alerts at both 15 and 30 minutes when worn on the abdomen.
3. Guardian™ Connect system SSED, page 19, Table 5. 98.5% Glucose Correct Detection Rate based on Predictive Alerts at 30 minutes when worn on the abdomen.
† Smart CGM predicts future high and low sensor glucose events up to 60 minutes in advance.
‡ Android is a trademark of Google LLC.
Important Safety Information: Guardian™ Connect CGM System
The Guardian™ Connect system requires a prescription and is indicated for continuous or periodic monitoring of glucose levels in the interstitial fluid under the skin, in patients (14 to 75 years of age) with diabetes mellitus. The system is intended to complement, not replace, information obtained from standard blood glucose monitoring devices, and is not recommended for people who are unwilling or unable to perform a minimum of two meter blood glucose tests per day, or for people who are unable or unwilling to maintain contact with their healthcare professional. The system requires a functioning mobile electronic device with correct settings. If the mobile device is not set up or used correctly, you may not receive sensor glucose information or alerts. For complete details of the system and its components, including warnings, contraindications, and precautions, please consult the user guide at http://www.medtronicdiabetes.com/support/download-library/user-guides and important safety information.
Important Safety Information: Sugar.IQ™ App
The Sugar.IQ™ app (MMT-8100) helps manage diabetes by facilitating the logging and display of meal entries and sensor glucose (SG) data, tracking meal log entries, reporting insights of how meals affect glucose levels, and supporting good choices and trends with motivational messages. The app serves as an additional display for real-time CGM data from the Guardian™ Connect system through the CareLink™ Personal software. It is not intended to provide medical advice and should not be relied upon for such purpose. The app is not intended to replace the real-time display of the CGM data on the Guardian™ Connect app, control any functions of the connecting device, calculate insulin or other drug doses, or modify date or control functions of the Guardian™ Connect system. All therapy decisions should be made by the app user based on blood glucose (BG) measurements obtained from a BG meter. Changes to treatment should only be made in consultation with a healthcare professional (HCP). For complete details, consult the user guide at http://www.medtronicdiabetes.com/support/download-library/user-guides and important safety information.
The system is intended to complement, not replace, information obtained from standard blood glucose monitoring devices. All therapy adjustments should be based on measurements obtained from standard blood glucose monitoring devices and not on values provided by the system.
Important Safety Information: CareLink™ Software
The CareLink™ software is intended for use as a tool to help manage diabetes. The purpose of the software is to take information transmitted from insulin pumps, glucose meters and continuous glucose monitoring systems, and turn it into CareLink™ reports. The reports provide information that can be used to identify trends and track daily activities—such as carbohydrates consumed, meal times, insulin delivery, and glucose readings. NOTE: CareLink™ report data is intended for use as an adjunct in the management of diabetes only and NOT intended to be relied upon by itself. Patients should consult their healthcare providers familiar with the management of diabetes prior to making changes in treatment. For more details, please consult important safety information. and the appropriate CareLink™ User Guide at http://www.medtronicdiabetes.com/support/download-library/user-guides.
Important Safety Information: i-Port Advance™ Injection Port
i-Port Advance™ injection port is indicated for patients who administer or receive multiple daily subcutaneous injections of physician prescribed medications, including insulin. The device may remain in place for up to 72 hours to accommodate multiple injections without the discomfort of additional needle sticks. i-Port Advance™ injection port may be used on a wide range of patients, including adults and children. Prescription required. For more, please see http://www.medtronicdiabetes.com/important-safety-information.
© Medtronic. All rights reserved. Medtronic, Medtronic logo and Further, Together are trademarks of Medtronic. Third party brands are trademarks of their respective owners. All other brands are trademarks of a Medtronic company.